The Clinical and Laboratory Standards Institute (CLSI) announced the implementation of new Country-Based Pricing for countries that meet economic criteria set forth by the World Bank.
Effective immediately, this pricing structure will enable laboratories and clinicians around the world, regardless of resources, to more feasibly access CLSI’s robust library of standards documents, training and support materials, and membership.
CLSI’s Country-Based Pricing structure correlates to World Bank Income Groups, which are determined by each country’s gross national income, and updated annually in August. Under this model, low- and lower-middle income countries receive a 90% price discount. Upper-middle income countries receive a 50% discount off list prices.
In total, Country-Based Pricing offers new discounted pricing to more than 136 lower- and middle- income countries this year. Discounts are applied upon purchase and / or the establishment of a new CLSI membership, or on renewal dates for current members. These discounts apply to well over 350 critical laboratory resources such as CLSI M100 – Performance Standards for Antimicrobial Susceptibility Testing, Evaluation Protocol guidelines, Point-of-Care Testing and Newborn Screening resources, and Quality Management essentials.
In 2023, CLSI piloted Country-Based Pricing for laboratories and clinicians in India. Members and applicants operating in any of the States of India were eligible for a 90% discount. The pilot generated significant increases in the usage of both paid and free documents (746% and 149%, respectively, YOY), and users (313% YOY), in India, contributing significantly to improved laboratory practices for the people of India.
